AIM
TAK icon

ARK Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

ARK Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,862,379
Closed -$107M – 384
2021
Q4 		$107M Sell
7,862,379
-5,639,271
-42% -$79.1M 0.32% 55
2021
Q3 		$221M Sell
13,501,650
-1,991,347
-13% -$33.4M 0.53% 42
2021
Q2 		$261M Sell
15,492,997
-3,224,147
-17% -$54.9M 0.49% 53
2021
Q1 		$342M Buy
18,717,144
+10,098,979
+117% +$182M 0.68% 46
2020
Q4 		$157M Buy
8,618,165
+7,461,868
+645% +$131M 0.42% 59
2020
Q3 		$20.6M Buy
+1,156,297
New +$21.1M 0.12% 89

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ARK Investment Management's TAK Position: Q1 2022 in Review

ARK Investment Management sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 7,862,379 shares — an estimated $107M sold.

ARK Investment Management first reported a position in TAK in Q3 2020 and held it in 6 quarters. The position peaked at $342M in Q1 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • ARK Investment Management reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • ARK Investment Management sold 7,862,379 Takeda Pharmaceutical shares in Q1 2022, an estimated $107M.
  • ARK Investment Management first reported a position in Takeda Pharmaceutical in Q3 2020 and held it in 6 quarters.
  • ARK Investment Management's Takeda Pharmaceutical position peaked at $342M in Q1 2021.
  • 288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.